“…Most prior studies have focused on signaling via IL-7 (Dibirdik et al, 1991;Barata et al, 2004aBarata et al, ,b,c, 2005González-Garcia et al, 2009;Shochat et al, 2011;Silva et al, 2011) or mutational activation of intermediates in the PI3K-Akt pathway Gutierrez et al, 2009). The importance of PI3K-Akt activation in T-ALL is underscored by multiple studies showing that PI3K-Akt/mTOR inhibitors block growth/survival of T-ALL cells (Avellino et al, 2005;Wei et al, 2006;Palomero et al, 2007;Chiarini et al, 2009;Cullion et al, 2009).…”